ID   USA1_YEAST              Reviewed;         838 AA.
AC   Q03714; D6VZE5;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   07-APR-2021, entry version 173.
DE   RecName: Full=U1 SNP1-associating protein 1;
GN   Name=USA1; OrderedLocusNames=YML029W;
OS   Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast).
OC   Eukaryota; Fungi; Dikarya; Ascomycota; Saccharomycotina; Saccharomycetes;
OC   Saccharomycetales; Saccharomycetaceae; Saccharomyces.
OX   NCBI_TaxID=559292;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=9169872;
RA   Bowman S., Churcher C.M., Badcock K., Brown D., Chillingworth T.,
RA   Connor R., Dedman K., Devlin K., Gentles S., Hamlin N., Hunt S., Jagels K.,
RA   Lye G., Moule S., Odell C., Pearson D., Rajandream M.A., Rice P.,
RA   Skelton J., Walsh S.V., Whitehead S., Barrell B.G.;
RT   "The nucleotide sequence of Saccharomyces cerevisiae chromosome XIII.";
RL   Nature 387:90-93(1997).
RN   [2]
RP   GENOME REANNOTATION.
RC   STRAIN=ATCC 204508 / S288c;
RX   PubMed=24374639; DOI=10.1534/g3.113.008995;
RA   Engel S.R., Dietrich F.S., Fisk D.G., Binkley G., Balakrishnan R.,
RA   Costanzo M.C., Dwight S.S., Hitz B.C., Karra K., Nash R.S., Weng S.,
RA   Wong E.D., Lloyd P., Skrzypek M.S., Miyasato S.R., Simison M., Cherry J.M.;
RT   "The reference genome sequence of Saccharomyces cerevisiae: Then and now.";
RL   G3 (Bethesda) 4:389-398(2014).
RN   [3]
RP   LEVEL OF PROTEIN EXPRESSION [LARGE SCALE ANALYSIS].
RX   PubMed=14562106; DOI=10.1038/nature02046;
RA   Ghaemmaghami S., Huh W.-K., Bower K., Howson R.W., Belle A., Dephoure N.,
RA   O'Shea E.K., Weissman J.S.;
RT   "Global analysis of protein expression in yeast.";
RL   Nature 425:737-741(2003).
RN   [4]
RP   FUNCTION, IDENTIFICATION IN THE HRD1 COMPLEX, INTERACTION WITH UBX2; HRD1;
RP   HRD3; DER1; YOS9 AND CDC48, AND DISRUPTION PHENOTYPE.
RX   PubMed=16873066; DOI=10.1016/j.cell.2006.05.043;
RA   Carvalho P., Goder V., Rapoport T.A.;
RT   "Distinct ubiquitin-ligase complexes define convergent pathways for the
RT   degradation of ER proteins.";
RL   Cell 126:361-373(2006).
RN   [5]
RP   TOPOLOGY [LARGE SCALE ANALYSIS].
RC   STRAIN=ATCC 208353 / W303-1A;
RX   PubMed=16847258; DOI=10.1073/pnas.0604075103;
RA   Kim H., Melen K., Oesterberg M., von Heijne G.;
RT   "A global topology map of the Saccharomyces cerevisiae membrane proteome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:11142-11147(2006).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-376 AND SER-379, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   STRAIN=ADR376;
RX   PubMed=17330950; DOI=10.1021/pr060559j;
RA   Li X., Gerber S.A., Rudner A.D., Beausoleil S.A., Haas W., Villen J.,
RA   Elias J.E., Gygi S.P.;
RT   "Large-scale phosphorylation analysis of alpha-factor-arrested
RT   Saccharomyces cerevisiae.";
RL   J. Proteome Res. 6:1190-1197(2007).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18407956; DOI=10.1074/mcp.m700468-mcp200;
RA   Albuquerque C.P., Smolka M.B., Payne S.H., Bafna V., Eng J., Zhou H.;
RT   "A multidimensional chromatography technology for in-depth phosphoproteome
RT   analysis.";
RL   Mol. Cell. Proteomics 7:1389-1396(2008).
RN   [8]
RP   FUNCTION, INTERACTION WITH DER1 AND HRD1, AND DISRUPTION PHENOTYPE.
RX   PubMed=20005842; DOI=10.1016/j.molcel.2009.10.015;
RA   Horn S.C., Hanna J., Hirsch C., Volkwein C., Schutz A., Heinemann U.,
RA   Sommer T., Jarosch E.;
RT   "Usa1 functions as a scaffold of the HRD-ubiquitin ligase.";
RL   Mol. Cell 36:782-793(2009).
RN   [9]
RP   FUNCTION, INTERACTION WITH HRD1 AND HRD3, SUBCELLULAR LOCATION, DISRUPTION
RP   PHENOTYPE, CHARACTERIZATION OF UBIQUITIN-LIKE DOMAIN, AND CHARACTERIZATION
RP   OF FUNCTIONAL REGIONS.
RX   PubMed=19898607; DOI=10.1371/journal.pone.0007604;
RA   Kim I., Li Y., Muniz P., Rao H.;
RT   "Usa1 protein facilitates substrate ubiquitylation through two separate
RT   domains.";
RL   PLoS ONE 4:E7604-E7604(2009).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-374; SER-376 AND SER-379, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19779198; DOI=10.1126/science.1172867;
RA   Holt L.J., Tuch B.B., Villen J., Johnson A.D., Gygi S.P., Morgan D.O.;
RT   "Global analysis of Cdk1 substrate phosphorylation sites provides insights
RT   into evolution.";
RL   Science 325:1682-1686(2009).
RN   [11]
RP   FUNCTION, INTERACTION WITH HRD1, DISRUPTION PHENOTYPE, CHARACTERIZATION OF
RP   UBIQUITIN-LIKE DOMAIN, AND CHARACTERIZATION OF FUNCTIONAL REGIONS.
RX   PubMed=21074049; DOI=10.1016/j.cell.2010.10.028;
RA   Carvalho P., Stanley A.M., Rapoport T.A.;
RT   "Retrotranslocation of a misfolded luminal ER protein by the ubiquitin-
RT   ligase Hrd1p.";
RL   Cell 143:579-591(2010).
RN   [12]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND CHARACTERIZATION OF UBIQUITIN-LIKE
RP   DOMAIN.
RX   PubMed=19940128; DOI=10.1074/jbc.m109.067876;
RA   Carroll S.M., Hampton R.Y.;
RT   "Usa1p is required for optimal function and regulation of the Hrd1p
RT   endoplasmic reticulum-associated degradation ubiquitin ligase.";
RL   J. Biol. Chem. 285:5146-5156(2010).
CC   -!- FUNCTION: Scaffold protein of the endoplasmic reticulum-associated
CC       degradation (ERAD) (also known as endoplasmic reticulum quality
CC       control, ERQC) pathway involved in ubiquitin-dependent degradation of
CC       misfolded endoplasmic reticulum proteins. Component of the HRD1
CC       ubiquitin ligase complex, which is part of the ERAD-L and ERAD-M
CC       pathways responsible for the rapid degradation of soluble lumenal and
CC       membrane proteins with misfolded lumenal domains (ERAD-L), or ER-
CC       membrane proteins with misfolded transmembrane domains (ERAD-M). Has
CC       multiple functions in ERAD including recruitment of DER1 to the HRD1
CC       ubiquitin ligase, and regulation of HRD1 activity. Involved in
CC       oligomerization of HRD1, which is required for ERAD-L, and in HRD1
CC       autoubiquitination and degradation. {ECO:0000269|PubMed:16873066,
CC       ECO:0000269|PubMed:19898607, ECO:0000269|PubMed:19940128,
CC       ECO:0000269|PubMed:20005842, ECO:0000269|PubMed:21074049}.
CC   -!- SUBUNIT: Component of the HRD1 complex which contains HRD1, HRD3, USA1,
CC       DER1, YOS9, CDC48, NPL4, UFD1 AND UBX2/SEL1. The complex is composed of
CC       the core membrane complex, consisting of the E3 ligase HRD1 and its
CC       cofactors HRD3, DER1 and USA1, the substrate recruiting factor YOS9,
CC       and the heterotrimeric UFD1-NPL4-CDC48/p97 (UNC) ATPase complex
CC       recruited by UBX2/SEL1. Interacts with DER1, HRD1, HRD3, YOS9, UBX2,
CC       and CDC48. {ECO:0000269|PubMed:16873066, ECO:0000269|PubMed:19898607,
CC       ECO:0000269|PubMed:20005842, ECO:0000269|PubMed:21074049}.
CC   -!- INTERACTION:
CC       Q03714; P38307: DER1; NbExp=3; IntAct=EBI-27760, EBI-5761;
CC       Q03714; Q03714: USA1; NbExp=2; IntAct=EBI-27760, EBI-27760;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:19898607}; Multi-pass membrane protein
CC       {ECO:0000269|PubMed:19898607}.
CC   -!- DOMAIN: The ubiquitin-like domain is required for HRD1 trans-
CC       ubiquitination and degradation. Reported to be involved in ERAD-M but
CC       not ERAD-L function (PubMed:20005842). However, a contradictory report
CC       states that it is not required for either ERAD-L or ERAD-M function
CC       (PubMed:19940128). Reported to be required for HRD1 oligomer formation
CC       (PubMed:19940128). However, a contradictory report does not observe any
CC       defects in oligomerization following deletion of the domain
CC       (PubMed:21074049). {ECO:0000269|PubMed:19940128,
CC       ECO:0000269|PubMed:20005842, ECO:0000269|PubMed:21074049}.
CC   -!- DISRUPTION PHENOTYPE: Impaired degradation of proteins with misfolded
CC       lumenal domains such as CPY*, a mutant, misfolded form of
CC       carboxypeptidase Y which is a known ERAD-L substrate. Impaired
CC       degradation of proteins with misfolded intramembrane domains. Impaired
CC       trans-ubiquitination and degradation of the HRD1 ligase. Degradation of
CC       proteins with misfolded cytosolic domains is not affected. Interaction
CC       of substrate with HRD1 is reduced; in USA1 and YOS9 double mutants this
CC       interaction is completely abolished. {ECO:0000269|PubMed:16873066,
CC       ECO:0000269|PubMed:19898607, ECO:0000269|PubMed:19940128,
CC       ECO:0000269|PubMed:20005842, ECO:0000269|PubMed:21074049}.
CC   -!- MISCELLANEOUS: Present with 1890 molecules/cell in log phase SD medium.
CC       {ECO:0000269|PubMed:14562106}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z46659; CAA86626.1; -; Genomic_DNA.
DR   EMBL; BK006946; DAA09869.1; -; Genomic_DNA.
DR   PIR; S49750; S49750.
DR   RefSeq; NP_013683.1; NM_001182387.1.
DR   PDB; 6VJZ; EM; 4.30 A; D=500-838.
DR   PDB; 6VK0; EM; 4.10 A; D=500-838.
DR   PDBsum; 6VJZ; -.
DR   PDBsum; 6VK0; -.
DR   SMR; Q03714; -.
DR   BioGRID; 35140; 136.
DR   ComplexPortal; CPX-3070; HRD1 ubiquitin ligase complex.
DR   DIP; DIP-6423N; -.
DR   IntAct; Q03714; 29.
DR   MINT; Q03714; -.
DR   STRING; 4932.YML029W; -.
DR   CarbonylDB; Q03714; -.
DR   iPTMnet; Q03714; -.
DR   MaxQB; Q03714; -.
DR   PaxDb; Q03714; -.
DR   PRIDE; Q03714; -.
DR   EnsemblFungi; YML029W_mRNA; YML029W; YML029W.
DR   GeneID; 854979; -.
DR   KEGG; sce:YML029W; -.
DR   SGD; S000004491; USA1.
DR   VEuPathDB; FungiDB:YML029W; -.
DR   eggNOG; ENOG502QUV9; Eukaryota.
DR   HOGENOM; CLU_337435_0_0_1; -.
DR   InParanoid; Q03714; -.
DR   OMA; EPGPGFW; -.
DR   PRO; PR:Q03714; -.
DR   Proteomes; UP000002311; Chromosome XIII.
DR   RNAct; Q03714; protein.
DR   GO; GO:0005783; C:endoplasmic reticulum; HDA:SGD.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IPI:SGD.
DR   GO; GO:0000839; C:Hrd1p ubiquitin ligase ERAD-L complex; IDA:SGD.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0060090; F:molecular adaptor activity; IDA:SGD.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IPI:SGD.
DR   GO; GO:1902499; P:positive regulation of protein autoubiquitination; IDA:SGD.
DR   GO; GO:0030433; P:ubiquitin-dependent ERAD pathway; IMP:SGD.
DR   InterPro; IPR000626; Ubiquitin-like_dom.
DR   InterPro; IPR029071; Ubiquitin-like_domsf.
DR   SUPFAM; SSF54236; SSF54236; 1.
DR   PROSITE; PS50053; UBIQUITIN_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Endoplasmic reticulum; Membrane; Phosphoprotein;
KW   Reference proteome; Transmembrane; Transmembrane helix.
FT   CHAIN           1..838
FT                   /note="U1 SNP1-associating protein 1"
FT                   /id="PRO_0000114926"
FT   TOPO_DOM        1..536
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        537..559
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        560..563
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        564..583
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        584..838
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          259..318
FT                   /note="Ubiquitin-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00214"
FT   REGION          31..240
FT                   /note="Required for ERAD-L function"
FT   REGION          319..418
FT                   /note="Important for HRD1 oligomer formation"
FT   REGION          345..535
FT                   /note="Interaction with HRD1"
FT   REGION          437..490
FT                   /note="Required for ERAD-L function and HRD1 oligomer
FT                   formation"
FT   REGION          584..838
FT                   /note="Interaction with DER1"
FT   MOD_RES         374
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19779198"
FT   MOD_RES         376
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17330950,
FT                   ECO:0007744|PubMed:19779198"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17330950,
FT                   ECO:0007744|PubMed:19779198"
SQ   SEQUENCE   838 AA;  96653 MW;  9B93ECA6C5421FD6 CRC64;
     MSEYLAQTPC KFTIWSSEID LIRTNLLVNA HPLSTVGRLL QYIHYQIYKQ LRAIYQPEEQ
     CTNSEIPHTP LNSINTYFLS YEGRELSATC LLKDITSSSH PDSNHFIRLQ LEKRTSPSGS
     AFDLEYDMEG EFNSMNIQFE INTLSSQRIF NSMEPNLPIG TTLARLEKLA LERIKDFEKS
     AGNLCGIKED HSVSDLQGFI IKGKQTPMFL NYGSDSDYYK DLNLVDLIGI DFAPAHNSFF
     TFLFKMNHEQ NSHIANDEER FVLEFISDAT LSITQMNVKP DTTVKQVKDF ICSVYTHSLN
     LRRNDIKLIY KGQLLHENNF AGNSSKISEY IKEPHEVKVH VQINQEYTES GPGFWNEVFN
     NPNIFQFMPP DTRSQSPVSF APTQGRSPAA IRGEERGIPY VTESGNDIVP TDELYRKCII
     NGDEVVFIPV SELNPQSSYL SVIKGDYGEI KIPISSNDYR INGDNILLSP SAIEQLESAL
     NFKIERPRDS TLLHPSGEHV RAADNTSSAN DNNTVENDES AWNRRVVRPL RNSFPLLLVL
     IRTFYLIGYN SLVPFFIILE FGSFLPWKYI ILLSLLFIFR TVWNTQEVWN LWRDYLHLNE
     IDEVKFSQIK EFINSNSLTL NFYKKCKDTQ SAIDLLMIPN LHEQRLSVYS KYDIEYDTNT
     PDVGQLNLLF IKVLSGEIPK DALDELFKEF FELYETTRNM NTLYPQDSLN ELLLMIWKES
     QKKDINTLPK YRRWFQTLCS QIAEHNVLDV VLRYIIPDPV NDRVITAVIK NFVLFWVTLL
     PYVKEKLDDI VAQRARDREQ PAPSAQQQEN EDEALIIPDE EEPTATGAQP HLYIPDED
//
